The way to prevent anemia

 

(57) Abstract:

Prevention and treatment of nutritional, iron deficiency anaemia in piglets produced iron therapy. The current scheme provides for a double intramuscular injection of iron supplementation in a dose of 2-8 ml/goal in the first 10 days of life animals (100-375 mg Fe). The proposed method replaces the re-injection of iron solution containing glycinate zinc, glycinate copper and potassium iodide. This increases the intensity of hemopoiesis, faster than normal hematological indices, protein, carbohydrate and mineral metabolism, and increase liveweight gain and safety of young pigs. table 1.

The invention relates to the field of veterinary pharmacology and can be used for the prevention and treatment of hypochromic microcytic anemia.

In veterinary practice known methods of prevention and treatment of iron deficiency anaemia in piglets relatedactivity drugs, a binder component which are modified carbohydrates. In particular, widely used for this purpose, feroglobin (Karelin A. I., 1983).

The current scheme provides for Fe3+).

The disadvantage of the used devices is that they do not take into account the variety of factors affecting haematopoiesis from mineral metabolism (Jones, L. M., 1971).

Antianemic action iron preparations may be reinforced by the application of some other trace elements such as zinc, copper and iodine. The influence of the latter on the blood largely mediated through enzymatic system of the biosynthesis of hemoglobin and thyroid function.

Drugs, containing both zinc, copper and iodine to enhance Antianemic action feroglobin and other iron compounds. This is due to the fact that in solutions of compounds of zinc, copper and iodine react with each other with the formation of precipitation (CuO, CuJ2).

The aim of the invention is the obtaining and the use is compatible in solution compounds of zinc, copper and iodine to enhance Antianemic action feroglobin.

This goal is achieved by intramuscular injection of animals with a solution containing both glycinate zinc, glycinate copper and potassium iodide, after pretreatment with them feroglobin.

An example implementation spov. The experience lasted for 60 days (from birth to weaning). Piglets were weighed at birth and in the subsequent ten, analysis of hematological data were produced at 1, 12 and 23 days of life of animals.

On the 2nd day of life of the piglets experimental and control groups was injecion intramuscularly in the parotid region 2 ml feroglobin (150 mg, Fe+). On the 5th day the piglets from the experimental group were injected with 2 ml of a solution containing glycinate zinc, glycinate copper and potassium iodide, and the control animals was re-injection feroglobin dose of 3 ml/bird (225 mg Fe3+).

During the experiment, there was a dynamic hematological parameters. In the experimental group animals showed a trend of increase in the number of erythrocytes, hemoglobin concentrations and hematocrit values in the earlier period compared to control. The data presented in the table.

The average live weight of piglets under the influence of glycinate zinc, glycinato copper and potassium iodide in combination with ferroaluminum to the weaning period in the experimental group increased by 11.8% compared to control.

Scientific-technical literature and technical documentation

1. Karelin A. I. Anemia piglets. M: Rosselchozizdat, 1983, S. 58, S. 132.

 

Same patents:

The invention relates to medicine and veterinary

The invention relates to livestock and can be used in pig production to replenish iodine deficiency in sows

The invention relates to the pharmaceutical industry, in particular, to methods of producing products with mineral filler with a specific type of release used in VETERINARII with bactericidal and wound-healing effect
The invention relates to biotechnology and can be used in the production of Baker's yeast, medical drugs, food and feed additives derived from yeast biomass
The invention relates to veterinary and zootechnique and can be used to improve productivity, therapy and prevention of metabolic substance in ewes, prevention of metabolic diseases in lambs
The invention relates to medicine, namely to dermatology, and relates to a method of topical treatment of fungal infections of the feet and smooth skin

The invention relates to the use of starch as a substance that forms a complex with iodine, for the learning of dry pharmaceutical compositions applicable in the form of capsules or tablets

Drug // 2121347

The invention relates to new chemical compounds, complexes of 1-vinyl - 1-ethylimidazole with zinc and cobalt salts of organic and inorganic acids with the General formula given in the description text

-oxyethyl)-2-methyl-5-nitroimidazol] zinc (ii) hydrate exhibiting bacteriostatic activity" target="_blank">

The invention relates to new derivatives of metronidazole [1-(-oxyethyl)-2-methyl-5-nitroimidazol] with bacteriostatic action and finds application in medicine

The invention relates to medicine, in particular to the treatment of polielementnom in patients with clinical manifestations of zinc States

The invention relates to medicine and for the production of the antidote
The invention relates to medicine, in particular to ginecologie and for the treatment of bacterial vaginosis and genital inflammation

Drug // 2121347

Remedy for pain // 2107503
The invention relates to medicine and can be used both in the inpatient and outpatient settings to reduce or eliminate pain syndrome

The invention relates to medicine, namely to methods for drugs

The invention relates to medicine, in particular to the technology of medicines, and can be used to produce mercury-containing drugs with antitumor activity

The invention relates to medicine and can be used to treat patients with benign and malignant diseases irrespective of their origin and localization, immunodeficiency different origin and radiation diseases, as well as for conflict prevention incompatible transplant, for pain relief and wound-healing
Up!